Reports of a potential merger of Cboe Global Markets' (CBOE) and CME Group (CME) could revive on perceived lack of revenue ...

In a report released today, Jeff Jones from Oppenheimer reiterated a Buy rating on Alumis Inc. (ALMS – Research Report), with a price target of ...

A live webcast will be available on the Alumis website in the "Investors" section under the “Events” page. About Alumis Alumis is a clinical-stage biopharmaceutical company developing oral therapies ...

Peter Oppenheimer, Goldman Sachs chief global equity strategist and head of macro research, joins 'Squawk Box' to discuss the latest market trends, why he believes that markets are vulnerable to a ...

Regal Rexnord (NYSE:RRX – Free Report) had its price objective reduced by Oppenheimer from $210.00 to $190.00 in a research note issued to investors on Friday,Benzinga reports. Oppenheimer currently ...

Oppenheimer cut shares of Cloudflare (NYSE:NET – Free Report) from an outperform rating to a market perform rating in a research note issued to investors on Friday morning, Marketbeat reports. Several ...

Christopher Nolan's next film will adapt Homer's epic poem 'The Odyssey,' and the cast is stacked for the feature film with a summer 2026 release date ...

Heather Perry made a bold bet before last year's holiday rush: switch all e-commerce operations of her family-owned roastery, ...

Oppenheimer analysts downgraded Pliant Therapeutics stock from Outperform to Perform, following a significant development ...

Miles Teller (“Whiplash, “Top Gun: Maverick”) and Casey Affleck (“Manchester By the Sea,” “Oppenheimer”) are set to lead the cast of pursuit thriller “Wild Game.” “Wild Game” comes from ...